Drug-induced interstitial lung disease
iatrogenic ILD · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Many drugs cause lung injury ranging from pneumonitis and organising pneumonia to fibrosis, including amiodarone, methotrexate, nitrofurantoin, bleomycin and immune-checkpoint inhibitors. Diagnosis is one of exclusion; prompt drug cessation is the cornerstone of treatment.
Red flags
- Rapidly worsening hypoxaemia / respiratory failure
- Grade 3-4 checkpoint-inhibitor pneumonitis
- Failure to improve after 48-72 h of steroids (reconsider infection)
- Diffuse alveolar haemorrhage features
Assessment
Differential diagnosis
- Infection (including opportunistic / PJP)
- Underlying disease progression (e.g. malignancy, connective tissue disease)
- Cardiogenic pulmonary oedema
- Radiation pneumonitis
- Diffuse alveolar haemorrhage
- Aspiration
Investigations
- Full drug and timeline history including over-the-counter and recent chemo/immunotherapy
- HRCT chest to define pattern (ground glass, organising pneumonia, NSIP, fibrosis)
- Spirometry and DLCO
- Bronchoscopy with BAL to exclude infection and characterise inflammation
- Infection screen (cultures, PJP, viral, galactomannan)
- Autoimmune serology to exclude CTD-ILD
Management
- Compile a complete medication history and correlate onset with each agent
- Exclude infection, cardiac failure and disease progression as mimics
- Obtain HRCT to characterise the injury pattern
- Perform BAL to exclude infection where safe
- Stop the suspected culprit drug immediately
- Assess severity (oxygenation, extent, trajectory) and grade checkpoint-inhibitor pneumonitis
- Start corticosteroids for symptomatic or moderate-severe pneumonitis
- For checkpoint-inhibitor pneumonitis, follow immune-toxicity grading and add additional immunosuppression if steroid-refractory
- Avoid 100% oxygen in bleomycin-exposed patients
- Document the reaction, avoid rechallenge and monitor recovery with serial imaging/physiology
Drugs & doses
Prednisolone 0.5-1 mg/kg/day PO (up to 1-2 mg/kg for severe/checkpoint pneumonitis) with slow taper
Methylprednisolone 1-2 mg/kg/day IV for severe grade 3-4 checkpoint pneumonitis
Infliximab 5 mg/kg IV or mycophenolate for steroid-refractory immune pneumonitis
Discontinue culprit (amiodarone, methotrexate, nitrofurantoin, bleomycin, checkpoint inhibitor)
Disposition
Admit moderate-severe cases; respiratory +/- oncology (immunotoxicity) MDT; discontinue drug and document reaction.
Complications & pitfalls
- Respiratory failure requiring ventilation
- Irreversible pulmonary fibrosis
- Opportunistic infection on immunosuppression
- Recurrence on inadvertent rechallenge
Exam pearls
- Amiodarone lung toxicity can appear months-years after starting and shows high-density pulmonary infiltrates
- Avoid high FiO2 in bleomycin-exposed patients peri-operatively
- Checkpoint-inhibitor pneumonitis can occur after therapy has stopped and needs grading-based management
- Always exclude infection by BAL before attributing to drug and starting steroids
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.